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MD
The benefits of powered mobility (PM) for people with severe disabilities are now better understood. By using powered wheelchairs, individuals can experience greater participation in activities such as education [1] [2] [3] [4] or work [1] [2] [3] 5 , and a range of social activities such as shopping 1-3;6;7;7;8 , church going 1;2;6;9 , socialising with family and friends 1;2;6;9;10 and accessing healthcare facilities 2;6;9;11 . In addition, the increased mobility provided by PM enhances quality of life and wellbeing 5;10;12 . Benefits to carers have also been reported 2;5;9;11 . However, it has been noted that there are problems associated with powered mobility (PM). For some wheelchair users (referred to as users), pain and discomfort remain problematic 1;13;14 as do difficulties with transport 5;9 and equipment breakdown or accidents 1;2;15 . Nonetheless, successful community dwelling and interaction involves activities that are dependent on a successful PM prescription minimising immobility. Studies generally have involved small numbers of users and are usually exploratory in nature, an issue also identified in the review of Greer et al 16 .
Recently, gaps have been identified and recommendations made for future studies to strengthen the evidence base. Research suggestions are to include people with different physical limitations, needs and goals 16 . Lack of standardisation of service delivery in the published literature is perceived as a problem to improving practice and understanding who might benefit from PM. Such information is needed to develop standards and guidelines 16 , and to identify groups of users who would justify additional expense, an issue of concern for policy makers and payers 16 .
There is a need to capture data from greater numbers representative of the population of wheelchair users 17 . Whilst such populations have been described 18 , the diagnoses, age and gender of a large and specific population of powered wheelchair users is lacking. Objectively verified data are needed for these factors as declarative data gathered through self-report surveys have been criticized for biases 18 The data relevant to this study had been recorded by health professionals following a physical examination and assessment and consisted of:-
Demographic data
• age at initial assessment
• gender
Medical factors
• Major diagnosis contributing to the need for a wheelchair as described previously 2 but with the addition of a category for inherited metabolic conditions.
• Ventilator issues
• Problematic pain -that needed intervention(s).
• (Kypho)scoliosis Users with multiple sclerosis (MS), cerebral palsy (CP), muscular dystrophy (MD), cerebrovascular disease (CVD), other neurological conditions, spina bifida (SB), spinal cord injury (SCI) and polio were grouped together as having neurological or neuromuscular conditions (NNCs).
Wheelchair factors
• Specialised seating (SS) -that which is needed by people who require a wheelchair but due to instability or deformity need additional support in order to function 21 , (similar to that of adaptive seating 22 )
• Tilt-in-space (TIS)
• Complex controls e.g. central joystick / tray mounted controls, head controls, switch controls, non-standard control system, interfacing with other assistive technology
Methods of analysis
Users were grouped by age according to the categories published by Warren 23 . We added one further category, 'under 16 years of age' (school children). These will be referred to as: Age group data were analysed to describe proportions and frequencies of variables to determine the range and pattern of the wheelchair and medical factors recorded.
T-tests were used with ratio and interval data to determine significant differences between sub-groups.
This study was approved by the National Research Ethics Service.
Results
The sample consisted of 544 users mean age 44.6 (range 7-92, sd 20. The largest diagnostic categories (Table 2) were CP (18.8%) and MS (16.5%). Males had conditions like MD and were younger whilst women had conditions such as MS and rheumatoid arthritis (RA) and were older. Three women were noted to have had a child whilst using an EPIOC. MS, CVD, RA, SCI, polio and amputation were not seen in Groups 1 and 2.
Conversely, those with CP, MD, SB and amputation were not seen in Group 5. Of those users with known diagnoses (n=542), 438 (81%) had neurological or NNC and 155 (29%) had the progressive conditions of MS and MD. Diagnoses associated with childhood (CP, MD, SB and inherited/metabolic conditions) constituted 39% (n=212) of the cohort.
Problematic pain was reported by 56 women and 43 men (18%) of the 544 users. There was no significant difference in age of those with or without problematic pain. Seventy six (77%) users reporting pain had NNC.
Eighty three (15%) had scoliosis, kyphus or both. Of the 83 users with a (kypho)scoliosis, 53 (64%) were provided with a TIS and 60 (72%) with SS. Forty one (49%) of those with scoliosis had CP or MD. The majority were in Groups 2 and 3 (n=52; 63%).
Equipment
One hundred and sixty nine users (31%) were provided with SS ( Recent recommendations emphasize the importance of motor and cognitive skills development and the ability to explore the environment as reasons for powered mobility being provided for very young children (aged 12-13 months onwards) [25] [26] [27] . In addition, early introduction of an EPIOC allows children and families to plan for future environmental adaptations and make proactive choices for housing and vehicles 27 . Consequently these issues need further publicity throughout the UK.
This study shows that this group is dominated by those with CP and MD requiring SS reflecting the development of scoliosis (with/without kyphus) during teenage years 21;28;29 . Tilt and recline functions are also indicated in this Group who are susceptible to hip and other joint contractures 30 and require pain and pressure relief 13;29;30 . EPIOCs provided for these children and those starting work are reported to facilitate greater functional mobility and to conserve energy for the physical demands of the workplace or college 31 . This has implications for payers or service commissioners as more chair functions will increase costs, in addition to the chair replacement costs consequent to user growth. Our findings demonstrate the provision of SS is low but with substantial numbers of users with MS and SCI, it is possible that they have residual motor functions sufficient to accommodate postural adjustments and movement in the chair and thus not need SS.
Furthermore, acquired impairments in adult life are unlikely to give rise to a scoliosis. As TIS has become more available on EPIOCs (and less expensive), it may be prescribed more frequently, offering greater comfort 13 , improved pressure relief 36 and relieving fatigue in conditions like MS.
Individuals in this Group may be developing their families and EPIOC provision would need to accommodate demands of parenthood. Although the literature has begun to explore the issues of parenthood for some of the major diagnosis found in our data, e.g. MS 37 , SB 38 , and SCI 39;40 we will also need more study of this issue for people with CP and MD as they live longer and may have expectations to become parents and to participate in child care these issues need addressing. The three mothers reported in our group are likely to be an underestimate as our study did not explore social and family issues. 
Study limitations
This study excludes users who bought wheelchairs privately. Our data did not record those who did not meet the criteria for provision, nor those who may have been eligible but were not referred.
As data were extracted from medical records that were designed for clinical use and not for research purposes, we experienced a small amount of missing information, an issue previously encountered by Karmarkar et al 7 . However, all data were extracted by the first author in a systematic manner.
We did not gather data on participation, or on parenthood which would have provided a more complete picture of the 554 EPIOC users. However, this information has been published for subgroups drawn from this population 1;9;11;12;29 . These studies demonstrated the limitations of NHS provision as well as considerable benefits to users and were most marked in the muscular dystrophy user group 29 . However, the data presented in this study represents the most appropriate EPIOC prescription that met the needs of each individual user according to the eligibility criteria -a limitation of the service.
The data represents a cross-sectional survey at a particular time which may limit generalisability to other powered wheelchair populations. Service reorganisation prevented further follow up to evaluate benefits.
Conclusions
Those with congenital and inherited conditions account for almost 40% of the cohort. Due to the increased longevity of those with these conditions, our findings should inform future planning for payers of powered wheelchair services. These data confirm the increasing use of newer functions on powered wheelchairs (e.g. TIS). These features have associated additional costs and are provided predominantly to younger users, as is SS. This study provides outcomes of the EPIOC prescription for this heterogeneous group of very severely disabled people. 
